Fulgent Genetics, Inc. (FLGT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 400M 800M 1.2B Q4 '15: 9.6M Q1 '16: 11.4M Q2 '16: 13.2M Q3 '16: 15.3M Q4 '16: 18.3M Q1 '17: 20.1M Q2 '17: 20.8M Q3 '17: 20.3M Q4 '17: 18.7M Q1 '18: 18.1M Q2 '18: 18.8M Q3 '18: 20M Q4 '18: 21.4M Q1 '19: 22.1M Q2 '19: 25.1M Q3 '19: 29.8M Q4 '19: 32.5M Q1 '20: 34.9M Q2 '20: 43.8M Q3 '20: 135.1M Q4 '20: 421.7M Q1 '21: 773.4M Q2 '21: 909.7M Q3 '21: 1B Q4 '21: 992.6M Q1 '22: 953.4M Q2 '22: 925.1M Q3 '22: 802.9M Q4 '22: 619M Q1 '23: 364.9M Q2 '23: 307.4M Q3 '23: 286.4M Q4 '23: 289.2M Q1 '24: 287.5M Q2 '24: 290.7M Q3 '24: 277.8M Q4 '24: 283.5M Q1 '25: 292.4M Q2 '25: 303.2M Q3 '25: 315.5M Q4 '25: 322.7M Q1 '26: 320.3M Q2 '26: 323.9M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit TTM

0 300M 600M 900M Q4 '15: 4.5M Q1 '16: 5.7M Q2 '16: 6.9M Q3 '16: 7.7M Q4 '16: 11.6M Q1 '17: 12.9M Q2 '17: 13.1M Q3 '17: 12.4M Q4 '17: 10.2M Q1 '18: 8.6M Q2 '18: 8.7M Q3 '18: 9.5M Q4 '18: 10.7M Q1 '19: 11.2M Q2 '19: 13.1M Q3 '19: 16.6M Q4 '19: 18.4M Q1 '20: 19.7M Q2 '20: 24.5M Q3 '20: 93.5M Q4 '20: 331.9M Q1 '21: 613.6M Q2 '21: 721.8M Q3 '21: 830.7M Q4 '21: 777.1M Q1 '22: 734.2M Q2 '22: 681.8M Q3 '22: 543.5M Q4 '22: 366.9M Q1 '23: 143.2M Q2 '23: 98.5M Q3 '23: 92.2M Q4 '23: 104.5M Q1 '24: 107.7M Q2 '24: 113.7M Q3 '24: 100.6M Q4 '24: 107.2M Q1 '25: 113.5M Q2 '25: 121.4M Q3 '25: 130.1M Q4 '25: 130.9M Q1 '26: 124M Q2 '26: 115.3M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Income TTM

-300M 0 300M 600M 900M Q4 '15: -5M Q1 '16: -6M Q2 '16: -5.8M Q3 '16: -7.7M Q4 '16: 919K Q1 '17: 1.8M Q2 '17: 633K Q3 '17: -153K Q4 '17: -3.5M Q1 '18: -5.9M Q2 '18: -6.7M Q3 '18: -6.1M Q4 '18: -5.1M Q1 '19: -4.7M Q2 '19: -3.4M Q3 '19: -1M Q4 '19: -428K Q1 '20: -519K Q2 '20: 1.8M Q3 '20: 63.8M Q4 '20: 290.2M Q1 '21: 559M Q2 '21: 655.3M Q3 '21: 751M Q4 '21: 676M Q1 '22: 611M Q2 '22: 524.9M Q3 '22: 365.9M Q4 '22: 178.5M Q1 '23: -48.2M Q2 '23: -80.8M Q3 '23: -81M Q4 '23: -195.5M Q1 '24: -192.5M Q2 '24: -191.6M Q3 '24: -208.9M Q4 '24: -73.9M Q1 '25: -71.9M Q2 '25: -72.7M Q3 '25: -71M Q4 '25: -91.1M Q1 '26: -105.9M Q2 '26: -122.3M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income TTM

-200M 0 200M 400M 600M Q4 '15: -5.8M Q1 '16: -6.8M Q2 '16: -12M Q3 '16: -13.5M Q4 '16: -5.3M Q1 '17: -4.6M Q2 '17: -87K Q3 '17: -73K Q4 '17: -2.5M Q1 '18: -4.7M Q2 '18: -5.7M Q3 '18: -5.2M Q4 '18: -5.6M Q1 '19: -5.6M Q2 '19: -4.2M Q3 '19: -2.2M Q4 '19: -411K Q1 '20: -459K Q2 '20: 2.5M Q3 '20: 47.7M Q4 '20: 214.3M Q1 '21: 417M Q2 '21: 493.4M Q3 '21: 569.3M Q4 '21: 507.4M Q1 '22: 460.7M Q2 '22: 392.4M Q3 '22: 271.6M Q4 '22: 143.4M Q1 '23: -25.9M Q2 '23: -48.7M Q3 '23: -63.5M Q4 '23: -167.8M Q1 '24: -165.9M Q2 '24: -163.4M Q3 '24: -165M Q4 '24: -42.7M Q1 '25: -40.8M Q2 '25: -51M Q3 '25: -43M Q4 '25: -60.5M Q1 '26: -73.8M Q2 '26: -84.4M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue TTM

0 90M 180M 270M Q4 '15: 5.1M Q1 '16: 5.7M Q2 '16: 6.4M Q3 '16: 7.6M Q4 '16: 6.7M Q1 '17: 7.3M Q2 '17: 7.7M Q3 '17: 7.9M Q4 '17: 8.6M Q1 '18: 9.5M Q2 '18: 10.1M Q3 '18: 10.5M Q4 '18: 10.7M Q1 '19: 10.9M Q2 '19: 12M Q3 '19: 13.2M Q4 '19: 14.1M Q1 '20: 15.2M Q2 '20: 19.3M Q3 '20: 41.7M Q4 '20: 89.8M Q1 '21: 159.8M Q2 '21: 188M Q3 '21: 205.2M Q4 '21: 215.5M Q1 '22: 219.2M Q2 '22: 243.4M Q3 '22: 259.5M Q4 '22: 252.1M Q1 '23: 221.7M Q2 '23: 208.9M Q3 '23: 194.2M Q4 '23: 184.8M Q1 '24: 179.8M Q2 '24: 177M Q3 '24: 177.2M Q4 '24: 176.3M Q1 '25: 179M Q2 '25: 181.8M Q3 '25: 185.4M Q4 '25: 191.8M Q1 '26: 196.3M Q2 '26: 208.7M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Cash Flow TTM

-250M 0 250M 500M 750M Q3 '16: 2.6M Q4 '16: 4.4M Q1 '17: 5M Q2 '17: 4.1M Q3 '17: 3.8M Q4 '19: 5.5M Q1 '20: 5.8M Q2 '20: 744K Q3 '20: 6.3M Q4 '20: 140.6M Q1 '21: 372.4M Q2 '21: 453M Q3 '21: 595.7M Q4 '21: 538.6M Q1 '22: 493.8M Q2 '22: 428.8M Q3 '22: 297.4M Q4 '22: 253.5M Q1 '23: 57.2M Q2 '23: 55.8M Q3 '23: 45.3M Q4 '23: 27M Q1 '24: 42.2M Q2 '24: 36.7M Q3 '24: 11M Q4 '24: 21.1M Q1 '25: 9.4M Q2 '25: -25.1M Q3 '25: 1.5M Q4 '25: -101.6M Q1 '26: -90.1M Q2 '26: -83.7M Q2 '17 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow TTM

-200M 0 200M 400M 600M Q3 '16: -988K Q4 '16: 617K Q1 '17: 1.3M Q2 '17: -618K Q3 '17: 1.7M Q4 '19: 4.3M Q1 '20: 4M Q2 '20: -1M Q3 '20: -5.5M Q4 '20: 105.5M Q1 '21: 326.6M Q2 '21: 404.6M Q3 '21: 554.1M Q4 '21: 514.8M Q1 '22: 476.1M Q2 '22: 410.8M Q3 '22: 277.4M Q4 '22: 234.7M Q1 '23: 41.8M Q2 '23: 31.5M Q3 '23: 21.5M Q4 '23: 4.8M Q1 '24: 17.9M Q2 '24: 11.7M Q3 '24: -28.7M Q4 '24: -19.3M Q1 '25: -31.6M Q2 '25: -60M Q3 '25: -19.8M Q4 '25: -124.2M Q1 '26: -113.2M Q2 '26: -103.8M Q2 '17 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '16: 12.1M Q2 '16: 12.4K Q3 '16: 12.8M Q1 '17: 18.2M Q2 '17: 17.7M Q3 '17: 17.8M Q1 '18: 17.9M Q2 '18: 17.9M Q3 '18: 18M Q1 '19: 18.2M Q2 '19: 19M Q3 '19: 19.5M Q1 '20: 21.6M Q2 '20: 22.9M Q3 '20: 23.5M Q1 '21: 30.8M Q2 '21: 30.8M Q3 '21: 31.2M Q1 '22: 31.2M Q2 '22: 31.2M Q3 '22: 30.9M Q1 '23: 29.5M Q2 '23: 29.8M Q3 '23: 30M Q1 '24: 29.8M Q2 '24: 30.1M Q3 '24: 30.4M Q1 '25: 30.8M Q2 '25: 30.5M Q3 '25: 30.7M Q1 '26: 30.9M Q2 '26: 28M Q1 '17 Q2 '18 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q3 '17: 0.00 Q4 '17: -0.14 Q1 '18: -0.26 Q2 '18: -0.32 Q3 '18: -0.29 Q4 '18: -0.31 Q3 '17 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '18

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.